Ignite Creation Date:
2025-12-26 @ 11:08 AM
Ignite Modification Date:
2026-02-22 @ 7:22 PM
Study NCT ID:
NCT03692312
Status:
COMPLETED
Last Update Posted:
2025-10-08
First Post:
2018-03-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Tideglusib in Congenital Myotonic Dystrophy
Sponsor:
AMO Pharma Limited
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Congenital Myotonic Dystrophy | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Tideglusib | View |
| None | AMO-02-MD-2-003 | View |
| None | Congenital Myotonic Dystrophy | View |
| None | Myotonic Dystrophy | View |
| None | Dystrophia Myotonica | View |
| None | Myotonia Atrophica | View |
| None | Myotonia Dystrophica | View |
| None | Myotonic Dystrophy, Congenital | View |
| None | Steinert Disease | View |
| None | Steinert Myotonic Dystrophy | View |
| None | Steinert's Disease | View |